Entrada Therapeutics, Inc.

Q3 2026 13F Holders

Symbol
TRDA
CUSIP
29384C108
Type
Equity
Class
COM
Num filings
5
Total reported value, excl. options
$32.1 k
Manager Report Date Value ($000) Shares Option Type